Ironwood Pharmaceuticals Inc (IRWD)
Operating profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Operating income | US$ in thousands | -945,430 | 250,337 | 232,259 | 142,940 | 120,123 |
Revenue | US$ in thousands | 421,125 | 403,178 | 381,332 | 353,446 | 366,965 |
Operating profit margin | -224.50% | 62.09% | 60.91% | 40.44% | 32.73% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-945,430K ÷ $421,125K
= -224.50%
Ironwood Pharmaceuticals Inc's operating profit margin has shown fluctuations over the past five years, ranging from 27.32% in 2019 to 60.97% in 2022. In 2023, the operating profit margin decreased to 38.02%. This decrease could be attributed to various factors such as changes in revenue, cost structure, or operating efficiency. It is important for stakeholders to further investigate the drivers behind this decline to assess the company's operational performance and profitability.
Peer comparison
Dec 31, 2023
Company name
Symbol
Operating profit margin
Ironwood Pharmaceuticals Inc
IRWD
-224.50%
Abbott Laboratories
ABT
16.43%
AbbVie Inc
ABBV
23.49%
Alkermes Plc
ALKS
25.25%
Amphastar P
AMPH
30.57%
ANI Pharmaceuticals Inc
ANIP
10.34%
Arcus Biosciences Inc
RCUS
-290.60%
Biomarin Pharmaceutical Inc
BMRN
6.66%
Bristol-Myers Squibb Company
BMY
-20.64%
Catalent Inc
CTLT
-17.10%
Catalyst Pharmaceuticals Inc
CPRX
21.80%